Innovation-driven medical device and software solutions company Breg, Inc announced on Wednesday that it has named Dave Mowry as its new chief executive officer and Matt Simons as its new Chief Financial Officer.
Mowry, who is to continue to serve as the chairman of the board, said, 'After an evaluation of the business and market, during my time serving as interim CEO, my optimism about Breg's vast opportunities has only grown. We are excited about becoming the leader in an under-appreciated market segment. We are already building momentum within the business as we shift the focus toward true innovation and category and channel expansion. We have a long road ahead, but I have great confidence in the team as we build discipline and consistency to achieving our financial objectives both in the short and long term.'
Simons is an experienced senior financial executive with more than 25 years of strategic financial leadership experience. In the new role, Simons is to head the company's finance initiatives, business development efforts and accounting and finance teams.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business